Non-Opioid Pathway: New drug candidates aim to block unpleasantness while maintaining sensation. Major Backing: A $12 million NIH grant supports the preclinical development of this approach.

A new study identifies brain area 46 in the marmoset dorsolateral prefrontal cortex as a key regulator of mood-related ...